APA-referens (7:e uppl.)

Erlinge, D., Andersson, J., Fröbert, O., Törnerud, M., Hamid, M., Kellerth, T., . . . Lund University, F. o. M. (2024). Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART). The Lancet, 404(10464), 1750. https://doi.org/10.1016/S0140-6736(24)02227-X

Chicago-referens (17:e uppl.)

Erlinge, David, et al. "Bioadaptor Implant Versus Contemporary Drug-eluting Stent in Percutaneous Coronary Interventions in Sweden (INFINITY-SWEDEHEART)." The Lancet 404, no. 10464 (2024): 1750. https://doi.org/10.1016/S0140-6736(24)02227-X.

MLA-referens (9:e uppl.)

Erlinge, David, et al. "Bioadaptor Implant Versus Contemporary Drug-eluting Stent in Percutaneous Coronary Interventions in Sweden (INFINITY-SWEDEHEART)." The Lancet, vol. 404, no. 10464, 2024, p. 1750, https://doi.org/10.1016/S0140-6736(24)02227-X.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.